EBITDA for Martek Biosciences Reaches Twelve Year High
Stock Quote:(N/A:MATK)
09/16/2009
0.00
N/A
N/A
EBITDA for Martek Biosciences Reaches Twelve Year High
Last
Price Change
% Chg
Volume
New York, NY, September 16, 2009-EbitdaEXTRA reports that EBITDA for Martek Biosciences Corporation (NASDAQ:MATK) for its twelve months ended July 31, 2009 was $89,514,000, a 7.7% increase over the ye ... read full story
U.S. markets are up modestly in early trading as investors hope that a Greek austerity deal will be coming soon in order to avoid a chaotic default. The European Central Bank has made key concessions regarding its holdings of Greek government bonds, ... read full story
N/A 
